期刊文献+

曲美他嗪对冠心病心力衰竭患者心脏收缩和舒张功能的影响 被引量:1

Effect of trimetazidine on cardiac systolic and diastolic function in patients with chronic congestive heart failure due to coronary artery disease
下载PDF
导出
摘要 目的 :探讨曲美他嗪对冠心病慢性心力衰竭患者心脏收缩和舒张功能的影响。方法 :观察冠心病慢性心力衰竭患者4 5例 ,其中曲美他嗪组 2 3例 ,对照组 2 2例。分别测定用药前及用药 6月后两组患者的超声心动图心功能指标SV ,CO ,CIandLVEF ,VA ,VE ,VA/VE。结果 :用药 6月后曲美他嗪组患者的SV ,CO ,CI及LVEF较对照组显著增高 (P <0 .0 5 ) ,但VA ,VE及VA/VE与对照组相比无显著性差异 (P >0 .0 5 )。结论 :曲美他嗪通过改善缺血心肌细胞的能量代谢 ,可保护缺血心肌细胞的功能 ,从而改善心脏的收缩功能。 Objective:To investigate the effects of trimetazidine on cardiac systolic and diastolic function in patients with chronic congestive heart failure due to coronary artery disease.Methods:45 patients with chronic congestive heart failure due to coronary artery disease were divided into two groups,23 patients in trimetazidine group and 22 in placebo-control group.The echocardiogram indices of cardiac function of patients in two groups-SV,CO,CI,LVEF,VA,VE and VA/VE were measured before and after treatment.Results:The indexes SV,CO,CI and LVEF were significantly higher in trimetazidine group than those in control group(P<0.05),but no significant difference in VA,VE and VA/VE was observed between the two groups(P>0.05).Conclusion:Trimetazidine can improve systolic function of ischemic heart by improving the energy metabolism of ischemic heart.
出处 《重庆医科大学学报》 CAS CSCD 2003年第6期804-806,共3页 Journal of Chongqing Medical University
关键词 曲美他嗪 冠心病 心力衰竭 心功能 Trimetazidine Coronary artery disease Heart failure Cardiac function
  • 相关文献

参考文献5

  • 1Detry JM, Sellier P, Pennaforte S, et al. Trimetazidine: a new concept in thetreatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group [J]. Br J Clin Pharmacol, 1994; 37:279 - 288.
  • 2Michaelides AP, Spiropoulos K, Dimopoulos K. Antiangina efficacy of the combination of trimetazidine- propranolol compared with isosorbine dinitrate- propranolol in patients with stable angina[J]. Clin Drugs Invest, 1997; 13:8 - 14.
  • 3LevyS. Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators[J]. Am J Cardiol, 1995; 76:12B- 16B.
  • 4Lopaschuk GD, Kozak R. Trimetazidine inhibits fatty acid oxidation in the heart[J]. J Mol Cell Cardiol, 1998;30 :A112.
  • 5Allibardi S, Chierchia SL, Margonato V, et al. Effects of trimetazidine on metabolic and functional recovery of postischemic rat hearts[J]. Cardiovasc DrugsTher, 1998; 12:543 -549.

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部